This CE webinar will provide a comprehensive review of the pharmacology, efficacy, and safety of Oraverse. Since its FDA approval in 2008, Oraverse has been increasingly used in dental practice. There exists variation between dental providers on how it is marketed and used during the daily course of comprehensive dental care delivery. Using evidence based information including the introduction of a new study evaluating its real world use, the presentation will analyze and describe phentolamine mesylate’s role in current dental practice.
Upon completion of this CE webinar, the student will be able to: be familiarized with the pharmacology, efficacy, and safety of Oraverse and better understand its role in current dental practice.
disclaimer, bio and commercial disclosure